MOHAMMAD DADA: Open Payments
NPI 1457307043 · ROCKY HILL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,779 in 117 payments from 14 companies in 2025. Trend: 2023 $3,998 · 2024 $1,389 · 2025 $1,779
Food & beverage: $1,779
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $277 |
| Vanda Pharmaceuticals Inc. | 15 | $254 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $210 |
| Alkermes, Inc. | 11 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $170 |
| Otsuka America Pharmaceutical, Inc. | 11 | $149 |
| E.R. Squibb & Sons, L.L.C. | 5 | $126 |
| Axsome Therapeutics, Inc. | 4 | $104 |
| Janssen Pharmaceuticals, Inc | 4 | $84 |
| Supernus Pharmaceuticals, Inc. | 4 | $79 |
Products named: VRAYLAR, TRINTELLIX, ARISTADA, CAPLYTA, REXULTI, FANAPT, COBENFY, HETLIOZ.
Industry payments across CT — which companies pay providers there.
